Moshe “Mori” Arkin (born 1952/53) is an Israeli billionaire businessman, the founder and chairman of Arkin Holdings, a pharmaceutical company.
Early life
Mori Arkin is the son of Ziama Arkin, who died in 1972, when Mori was 19. Arkin has a degree in psychology and philosophy from Tel Aviv University.
Career
In 1961, his father Ziama Arkin founded Agis Industries, an Israeli pharmaceutical importer. Agis grew into a generic pharmaceutical manufacturer, and in 2005, Mori Arkin sold Agis to Perrigo for $390 million.
Arkin is the founder and chairman of Arkin Holdings, a pharmaceutical company. He is the co-founder and chairman of the Accelmed Fund.
Personal life
Arkin is married with three children, and lives in Herzliya Pituah, Israel.
Mori Arkin Net Worth: Mori Arkin is an Israeli investor who has a net worth of $1.05 billion. Mori Arkin has landed on the list of Israeli billionaires thanks to lucrative investments in the pharmaceutical company Perrigo and Israel’s largest bank, Hapoalim. Mori Arkin began his career in 1972 when he helped his father run a small Israeli drugs-distributing company. Arkin has gradually become fully integrated in the family business and he was the one to lead its transformation from a small firm into a generics manufacturer. In 1983, he incorporated the company as Agis Industries, running it under that name for two decades before selling it to Perrigo, the largest producer of private label over-the-counter pharmaceuticals in the USA. Today, he has invested a total of $100 million in around 15 medical startup companies, most of which are under the umbrella of Arkin Holdings.
Source: